This week, page-23

Still a lot of room for SP growth here. A lot of comparisons have been made between ISNs run to 80c and the potential of ALT. I'm looking forward to seeing if that comes to fruition. From memory, ISN got to a $200 mill MC. For ALT, that translates to a 25c SP. I don't know much about ISN, so can't really say what these comparisons are based on, other than we are both medical device manufacturers. Maybe someone better informed can offer an opinion here.
I'm very much looking forward to the upcoming news flow- results from the study, first sales and the quarterly should all come out within weeks. Very glad to be on board this one.